# ARHGDIB

## Overview
ARHGDIB is a gene that encodes the protein Rho GDP dissociation inhibitor beta, which is a critical regulator of the Rho family of GTPases. These GTPases are pivotal in various cellular processes, including cytoskeletal organization, cell migration, and cell cycle progression. The protein functions as a chaperone, maintaining Rho GTPases in their inactive GDP-bound state by inhibiting GDP dissociation, thus controlling their activity and ensuring proper cellular function (Cherfils2013Regulation; Garcia-Mata2011The). Rho GDP dissociation inhibitor beta is primarily localized in the cytoplasm, where it stabilizes inactive Rho GTPases, preventing their degradation and facilitating their availability for activation in response to cellular signals (Garcia-Mata2011The). This regulatory mechanism is crucial for processes such as cell migration, immune response, and cancer metastasis, highlighting the protein's role in both normal cellular function and disease states (Cho2019Regulation; Liu2021KDM6AARHGDIB).

## Structure


## Function
ARHGDIB, also known as Rho GDP dissociation inhibitor beta, plays a crucial role in regulating the Rho family of GTPases, which are involved in various cellular processes such as cytoskeletal organization, cell migration, and cell cycle progression. ARHGDIB functions by inhibiting the dissociation of GDP from Rho proteins, thereby maintaining them in an inactive state. This regulation is essential for controlling cell shape, motility, and growth (Cherfils2013Regulation; Garcia-Mata2011The).

In healthy human cells, ARHGDIB is primarily active in the cytoplasm, where it stabilizes a pool of inactive Rho GTPases. This stabilization prevents the rapid degradation of Rho GTPases, ensuring their availability for activation in response to specific cellular signals (Garcia-Mata2011The). ARHGDIB's role as a chaperone involves maintaining the solubility and proper localization of Rho GTPases, which is critical for their function in processes like cell migration and immune response (Cho2019Regulation; Garcia-Mata2011The).

ARHGDIB is also involved in the spatial and temporal regulation of Rho GTPase activity, acting as a chaperone that facilitates the correct targeting and recycling of these proteins between the cytosol and the plasma membrane (Cho2019Regulation). This regulation is vital for processes such as cell migration, invasion, and metastasis, particularly in the context of cancer (Cho2019Regulation).

## Clinical Significance
Alterations in the expression of the ARHGDIB gene, also known as Rho GDP dissociation inhibitor beta, have been implicated in various cancers. In renal cell carcinoma (RCC), elevated ARHGDIB expression is associated with tumor progression and neoangiogenesis, suggesting its potential as a therapeutic target for metastatic RCC (von2017Rho). In bladder cancer, ARHGDIB acts as a metastasis suppressor. Its expression is inversely correlated with metastatic status and is considered an independent prognostic marker for tumor recurrence. The KDM6A-ARHGDIB axis plays a crucial role in inhibiting bladder cancer metastasis by regulating Rac1 activity, which is essential for tumorigenesis and metastasis (Liu2021KDM6AARHGDIB). 

In contrast, ARHGDIB expression is linked to increased cell motility in breast cancer and tumor progression in gastric cancer (von2017Rho). The gene's role in stabilizing ARHGDIB mRNA through autophagy-mediated mechanisms has been shown to promote bladder cancer invasion, highlighting its complex involvement in cancer progression (Zhu2019ATG7). These findings underscore the dual role of ARHGDIB in cancer, acting as both a promoter and suppressor of metastasis depending on the cancer type and cellular context.

## Interactions
ARHGDIB, also known as Rho GDP dissociation inhibitor beta, is involved in several interactions with proteins that influence cell signaling pathways. It acts as a critical inhibitor of Rho GTPases, including Rac1, by binding to them and preventing the dissociation of GDP, thereby maintaining them in an inactive state. This interaction is significant in the context of metastasis suppression in bladder cancer cells, as ARHGDIB's binding to Rac1 leads to decreased Rac1 activity without altering total Rac1 protein levels (Liu2021KDM6AARHGDIB).

In colorectal cancer, a truncated form of ARHGDIB, known as DC-LyGDI, has been shown to interact strongly with radixin and moesin, members of the ERM protein family. This interaction is crucial for anchoring Rho family proteins to the cell membrane, promoting the activation of these proteins and enhancing cell invasiveness (Ota2004LyGDI).

ARHGDIB also plays a role in the stabilization of its mRNA through interactions with proteins involved in autophagy. ATG7-mediated autophagy promotes the degradation of HNRNPD, a protein that binds to ARHGDIB mRNA. This degradation reduces HNRNPD's interaction with ARHGDIB mRNA, leading to increased mRNA stability and promoting bladder cancer cell invasion (Zhu2019ATG7).


## References


[1. (Liu2021KDM6AARHGDIB) Lei Liu, Jianfeng Cui, Yajing Zhao, Xiaochen Liu, Lipeng Chen, Yangyang Xia, Yong Wang, Shouzhen Chen, Shuna Sun, Benkang Shi, and Yongxin Zou. Kdm6a-arhgdib axis blocks metastasis of bladder cancer by inhibiting rac1. Molecular Cancer, May 2021. URL: http://dx.doi.org/10.1186/s12943-021-01369-9, doi:10.1186/s12943-021-01369-9. This article has 40 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-021-01369-9)

[2. (von2017Rho) Christoph‑Alexander von Klot, Natalia Dubrowinskaja, Inga Peters, Jï¿½rg Hennenlotter, Axel Merseburger, Arnulf Stenzl, Markus Kuczyk, and Jï¿½rgen Serth. Rho gdp dissociation inhibitor‑β in renal cell carcinoma. Oncology Letters, October 2017. URL: http://dx.doi.org/10.3892/ol.2017.7233, doi:10.3892/ol.2017.7233. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2017.7233)

[3. (Garcia-Mata2011The) Rafael Garcia-Mata, Etienne Boulter, and Keith Burridge. The “invisible hand”: regulation of rho gtpases by rhogdis. Nature Reviews Molecular Cell Biology, 12(8):493–504, July 2011. URL: http://dx.doi.org/10.1038/nrm3153, doi:10.1038/nrm3153. This article has 441 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm3153)

[4. (Cherfils2013Regulation) Jacqueline Cherfils and Mahel Zeghouf. Regulation of small gtpases by gefs, gaps, and gdis. Physiological Reviews, 93(1):269–309, January 2013. URL: http://dx.doi.org/10.1152/physrev.00003.2012, doi:10.1152/physrev.00003.2012. This article has 943 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00003.2012)

[5. (Cho2019Regulation) Hee Jun Cho, Jong-Tae Kim, Kyoung Eun Baek, Bo-Yeon Kim, and Hee Gu Lee. Regulation of rho gtpases by rhogdis in human cancers. Cells, 8(9):1037, September 2019. URL: http://dx.doi.org/10.3390/cells8091037, doi:10.3390/cells8091037. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8091037)

[6. (Ota2004LyGDI) Takahide Ota, Masayo Maeda, Shiho Suto, and Masaaki Tatsuka. Lygdi functions in cancer metastasis by anchoring rho proteins to the cell membrane. Molecular Carcinogenesis, 39(4):206–220, March 2004. URL: http://dx.doi.org/10.1002/mc.20006, doi:10.1002/mc.20006. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mc.20006)

[7. (Zhu2019ATG7) Junlan Zhu, Zhongxian Tian, Yang Li, Xiaohui Hua, Dongyun Zhang, Jingxia Li, Honglei Jin, Jiheng Xu, Wei Chen, Beifang Niu, Xue‐Ru Wu, Sergio Comincini, Haishan Huang, and Chuanshu Huang. Atg7 promotes bladder cancer invasion via autophagy‐mediated increased arhgdib mrna stability. Advanced Science, February 2019. URL: http://dx.doi.org/10.1002/advs.201801927, doi:10.1002/advs.201801927. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/advs.201801927)